Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Speciality Medicines Ltd

BSE: 544738 · Pharmaceuticals & Biotechnology · 12 announcements

Share price
₹185.00
Market cap
₹162.5 Cr
Revenue (annual)
₹75.29 Cr
Net profit (annual)
₹13.03 Cr
P/E (TTM)
12.5×Sector 47.4×
Promoter holding
43.43%
FII holding
0.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:07 IST BSE
Regulatory Approval

Speciality Medicines Regulatory Approval

Speciality Medicines Limited received regulatory approval in Ethiopia for two additional pharmaceutical formulations, Olanzapine and Diazepam tablets. The company now has 12 registered products in Ethiopia.